ArticleFrontiers in sleep2025
Redefining telemedicine in obstructive sleep apnea management through artificial intelligence.
Article in Frontiers in sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rethinking Long-Term Follow-Up of CPAP Therapy in Obstructive Sleep Apnea: Toward Personalized and Integrated Care.Healthcare (Basel, Switzerland) · 2026Review
- Advancements, challenges, and prospects of explainable AI in sleep disordered breathing.Sleep & breathing = Schlaf & Atmung · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea (OSA) represents a significant and increasingly prevalent health burden, impacting individual patients through diminished quality of life, increased morbidity and mortality, as well as society at large, via reduced productivity and escalating healthcare and welfare expenditures. As a multifactorial and heterogeneous disorder, OSA encompasses diverse endotypes and phenotypes, necessitating personalized approaches to diagnosis and management in order to achieve optimal clinical outcomes. Modern telemedicine encompasses a broad spectrum of digital tools designed to enhance the efficiency and precision of care delivery for complex conditions. Recent years have witnessed the rapid integration of advanced telehealth technologies, including consumer-grade devices, into clinical practice. Simultaneously, artificial intelligence (AI) has emerged as a transformative force in healthcare, enabling the automation of routine tasks, advanced data analytics, and the generation of novel clinical hypotheses. Within this domain, large language models, a subclass of AI specializing in natural language processing, offer new opportunities for augmenting patient-provider interactions, including streamlining communication and triaging patient-reported data. Despite these technological advancements, the full potential of telemedicine in the management of OSA remains underexplored. However, its implementation is expanding, particularly in longitudinal care models involving large patient cohorts. This Perspective aims to synthesize current state-of-the-art developments and proposes a comprehensive, integrated framework that leverages telemedicine, AI, and a multidimensional understanding of comorbidities and treatable traits throughout the continuum of OSA care, from screening and diagnosis to adherence monitoring and treatment optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.